S5 E12: Does less GPs matter? PCNs & continuity; best drug in T2DM after metformin | NB Medical
 

S5 E12: Does less GPs matter? PCNs & continuity; best drug in T2DM after metformin

NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE
17th May 2024

If you are having difficulties listening to this Podcast, try to play this episode in Spotify

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode we think about the GP workforce courtesy of four papers in this month's BJGP - does more GPs boost life expectancy (of the patients...)? do PCNs help health inequalities? is practice-based continuity as good as individual continuity?

For a more directly clinical update, we look at new research in the BMJ on which is the best oral option in T2DM after metformin. Can the SGLT2 inhibitors prove their worth?

References

BJGP Does the shortage of GPs matter?

BJGP PCNs, deprivation and funding

BJGP Continuity in GP

BJGP Continuity in Norwegian GP

BMJ Best drug after metformin in T2DM


Join us at one of our upcoming courses or live webinars